Clinical Trial

A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression

Name: A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression — clinical trial record (NCT07485595)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-16.

Trial Details

NCT Number	NCT07485595
Lead Sponsor	Tasly Pharmaceutical Group Co., Ltd
Conditions	Depression
Enrollment	180 participants
Start Date	2026-04-30
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-08